Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML—long-term results of a prospective randomized intergroup study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemia (SAL) †
Titel:
Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML—long-term results of a prospective randomized intergroup study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemia (SAL) †
Auteur:
Thiel, A. Schetelig, J. Pönisch, W. Schäfer-Eckart, K. Aulitzky, W. Peter, N. Schulze, A. Maschmeyer, G. Neugebauer, S. Herbst, R. Hänel, A. Morgner, A. Kroschinsky, F. Bornhäuser, M. Lange, T. Wilhelm, M. Niederwieser, D. Ehninger, G. Fiedler, F. Hänel, M.